ECM
PAHC icon

ExodusPoint Capital Management’s Phibro Animal Health PAHC Stock Holding History

ExodusPoint Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,300
Closed -$57K – 2281
2020
Q3 		$57K Buy
+3,300
New +$70.4K ﹤0.01% 1628

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

ExodusPoint Capital Management's PAHC Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Phibro Animal Health (PAHC) in Q1 2026, closing a stake of 50,157 shares — an estimated $1.87M sold.

ExodusPoint Capital Management first reported a position in PAHC in Q3 2020 and held it in 8 quarters. The position peaked at $17.4M in Q2 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • ExodusPoint Capital Management reported no remaining Phibro Animal Health position as of Q1 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 50,157 Phibro Animal Health shares in Q1 2026, an estimated $1.87M.
  • ExodusPoint Capital Management first reported a position in Phibro Animal Health in Q3 2020 and held it in 8 quarters.
  • ExodusPoint Capital Management's Phibro Animal Health position peaked at $17.4M in Q2 2025.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.